Onconetix, Inc.
ONCO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,524 | $58 | $0 | $0 |
| % Growth | 4,217.3% | – | – | – |
| Cost of Goods Sold | $1,469 | $1,186 | $7 | $5 |
| Gross Profit | $1,055 | -$1,127 | -$7 | -$5 |
| % Margin | 41.8% | -1,927.9% | – | – |
| R&D Expenses | $154 | $1,949 | $4,130 | $1,325 |
| G&A Expenses | $11,232 | $14,771 | $9,352 | $2,092 |
| SG&A Expenses | $11,232 | $14,771 | $9,352 | $2,092 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $46,158 | $18,187 | $0 | $0 |
| Operating Expenses | $57,544 | $34,907 | $13,481 | $3,417 |
| Operating Income | -$56,489 | -$36,035 | -$13,481 | -$3,417 |
| % Margin | -2,238% | -61,634.5% | – | – |
| Other Income/Exp. Net | -$3,247 | -$1,388 | $61 | $0 |
| Pre-Tax Income | -$59,736 | -$37,422 | -$13,420 | -$3,417 |
| Tax Expense | -$1,045 | -$13 | $0 | $0 |
| Net Income | -$58,691 | -$37,410 | -$13,420 | -$3,417 |
| % Margin | -2,325.2% | -63,986.5% | – | – |
| EPS | -1,823.25 | -87.6 | -1.09 | -0.31 |
| % Growth | -1,981.3% | -7,936.7% | -251.6% | – |
| EPS Diluted | -1,823.25 | -87.6 | -1.09 | -0.31 |
| Weighted Avg Shares Out | 32 | 5 | 4 | 3 |
| Weighted Avg Shares Out Dil | 32 | 5 | 4 | 3 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1,408 | $672 | $0 | $0 |
| Depreciation & Amortization | $731 | $44 | $7 | $5 |
| EBITDA | -$57,597 | -$36,707 | -$13,413 | -$3,412 |
| % Margin | -2,281.9% | -62,784.1% | – | – |